They thought they were being vaccinated. It was a trial.
3 years, 10 months ago

They thought they were being vaccinated. It was a trial.

CNN  

A version of this story appeared in the February 26 edition of CNN’s Coronavirus: Fact vs. Fiction newsletter. “They told us it is the corona vaccine and we should get it so that we don’t fall sick,” said Yashoda Bai Yadav, a housewife from Bhopal who participated in the trial alongside her husband. Covid restrictions forced Russian diplomats to leave North Korea on a hand-pushed rail trolley Eight employees of Russia’s embassy in Pyongyang and their families spent more than 34 hours trying to leave North Korea this week, a grueling trip that ended with at least one diplomat pushing his luggage and young children on a railway trolley into Russian territory. ON OUR RADAR Britain’s Queen Elizabeth II says those refusing vaccines “ought to think about other people rather than themselves.” South Korea began its vaccine rollout on Friday as health authorities extended current social distancing measures and bans on gatherings of five or more people until March 14. TODAY’S PODCAST “Frankly, when the United States provides resources and gets out of the way, the Cherokee Nation does a wonderful job of delivering health care.” – Cherokee Nation Principal Chief Chuck Hoskin, Jr. Covid-19 has disproportionately hit Native American communities, but when it comes to vaccine distribution, tribal health providers are actually outpacing many states.

Health India Russia Trial Indian North Korea Cnn Russian Vaccine Cherokee Russian Diplomats  medical  covid19  thought  study  korea  help  vaccine  vaccinated  health  patients  trial  russian

History of this topic

Scientists find arthritis drug may treat long Covid inflammation
5 months, 1 week ago

Scientists find arthritis drug may treat long Covid inflammation

India Today  

Scientists have discovered a new cause of long Covid in the lungs. Their study, published in Science Translational Medicine, indicates that a treatment previously used for rheumatoid arthritis might be effective in halting the chronic inflammation associated with long Covid. The researchers at the University of Virginia School of Medicine analysed single-cell RNA sequencing data from the lower airways of …

Arthritis drug reduces death risk in patients hospitalised with Covid-19: Study
2 years, 10 months ago

Arthritis drug reduces death risk in patients hospitalised with Covid-19: Study

Hindustan Times  

An anti-inflammatory drug normally used to treat rheumatoid arthritis reduces the risk of death when given to hospitalised patients with severe Covid-19, according to a study led by researchers at the University of Oxford. Arthritis drug reduces death risk in patients hospitalised with Covid-19: Study The benefit of baricitinib is in addition to those of dexamethasone and tocilizumab, two other …

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment
2 years, 11 months ago

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment

News 18  

India has cut down on the use of the experimental drug Remdesivir and immunosuppressive drug Tocilizumab for the treatment of Covid-19. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with Covid-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the overuse of steroids, the protocol for …

Have Covid-19 And In Home Isolation? Govt Advises On Medicines To Be Taken
2 years, 11 months ago

Have Covid-19 And In Home Isolation? Govt Advises On Medicines To Be Taken

ABP News  

New Delhi: The government expressed concern over "misuse and overuse" of Covid-19 drugs as cases continue to spike in India driven by the highly transmissible Omicron variant. Addressing a press conference, NITI Aayog Member Dr VK Paul said Covid-19 patients in home isolation should take paracetamol for fever and for cough, Ayush syrup could be used. Dr VK Paul said …

Chandrakant Lahariya | FDA approval of Covid pill a sign of hope for the world
3 years ago

Chandrakant Lahariya | FDA approval of Covid pill a sign of hope for the world

Deccan Chronicle  

On December 22, the US Food and Drugs Administration approved an oral Covid-19 drug Paxlovid. This understanding has practical relevance in Covid-19 clinical management, that the antiviral drugs work better in the first phase and the immunomodulators, immunosuppressive/anti-inflammatory drugs in the later phase. Nearly all currently available Covid-19 drugs need to be given either intravenously or through injections, in hospital …

New drug could treat patients hospitalised with COVID-19 pneumonia: Lancet study
3 years ago

New drug could treat patients hospitalised with COVID-19 pneumonia: Lancet study

The Hindu  

A newly identified drug may be used to effectively treat some patients hospitalised with COVID-19 pneumonia, according to a study published in The Lancet Respiratory Medicine journal The team, including researchers from the University of Birmingham and the University of Oxford, U.K., tested namilumab— an antibody already in late-stage trials to treat rheumatoid arthritis —in patients hospitalised with COVID-19 pneumonia. …

How Macaulay Putras Ridiculed Covaxin and Data Proved Them Wrong
3 years, 1 month ago

How Macaulay Putras Ridiculed Covaxin and Data Proved Them Wrong

News 18  

The Phase III human clinical trials of Covaxin began in mid-November 2020, involving 26,000 volunteers, between 18 and 98 years of age, across 21 sites. It was India’s first and only Phase III study for a COVID-19 vaccine, and the largest Phase III efficacy trial ever conducted here for any vaccine. He said that if the East India Company had …

'A Citizen Suffering Due To State-Sponsored Vaccination Scheme': Kerala HC Orders Expeditious Redressal Of Plea Seeking Booster Shot For Intl Travel
3 years, 2 months ago

'A Citizen Suffering Due To State-Sponsored Vaccination Scheme': Kerala HC Orders Expeditious Redressal Of Plea Seeking Booster Shot For Intl Travel

Live Law  

The Kerala High Court on Tuesday directed the Centre to expeditiously redress the grievance of a petitioner seeking administration of the third dose of an internationally recognized Covid-19 vaccine for NRIs, who had already received two doses of Covaxin, which is not globally recognized for international travel.Justice P.V. The Kerala High Court on Tuesday directed the Centre to expeditiously redress …

From Merck’s Molnupiravir to Glenmark’s nasal spray, over 20 new drugs in pipeline for COVID-19
3 years, 3 months ago

From Merck’s Molnupiravir to Glenmark’s nasal spray, over 20 new drugs in pipeline for COVID-19

Firstpost  

While the market for these drugs may not be huge at present due to a drop in COVID-19 cases and extended timelines, experts believe that these drugs will help control future waves and protect people with weak immunity Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials …

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid
3 years, 3 months ago

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid

News 18  

Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials or approvals in India to treat Covid-19. “As the world needs Covid-19 vaccines, the world also needs proven and effective Covid-19 therapies,” Lahariya said. List of Drugs in the Pipeline US pharma giant Merck and Ridgeback Biotherapeutics’ oral …

WHO to trial malaria, arthritis drugs as COVID treatments
3 years, 4 months ago

WHO to trial malaria, arthritis drugs as COVID treatments

Al Jazeera  

Three drugs will be added to the UN agency’s global trial to test their efficacy in patients hospitalised with COVID-19. The World Health Organization will test three new drugs as potential treatments for people in hospital with severe COVID-19 as it expands its global trial to 52 countries. Artesunate is currently used for severe malaria, imatinib for certain cancers, and …

India, U.K. to conduct clinical trials of ‘Ashwagandha’ for promoting recovery from COVID-19
3 years, 5 months ago

India, U.K. to conduct clinical trials of ‘Ashwagandha’ for promoting recovery from COVID-19

The Hindu  

The Ministry of Ayush has collaborated with the U.K.'s London School of Hygiene and Tropical Medicine to conduct a study on ‘Ashwagandha’ for promoting recovery from COVID-19. A Ministry release said that the All India Institute of Ayurveda, an autonomous body under the Ministry of Ayush, and the LSHTM recently signed a Memorandum of Understanding to conduct clinical trials of …

India, UK to Conduct Clinical Trials of Ashwagandha for Promoting Recovery from Covid-19
3 years, 5 months ago

India, UK to Conduct Clinical Trials of Ashwagandha for Promoting Recovery from Covid-19

News 18  

vid-29The AYUSH Ministry has collaborated with UK’s London School of Hygiene and Tropical Medicine to conduct a study on Ashwagandha for promoting recovery from COVID-19. The All India Institute of Ayurveda, an autonomous body under the Ministry of AYUSH, and LSHTM recently signed a memorandum of understanding to conduct clinical trials of Ashwagandha on 2,000 people in three UK cities …

WHO adds ‘lifesaving’ drugs for severely ill COVID-19 patients
3 years, 6 months ago

WHO adds ‘lifesaving’ drugs for severely ill COVID-19 patients

Al Jazeera  

The World Health Organization has added “lifesaving” interleukin-6 receptor blockers to its list of treatments for COVID-19 – only the second drugs to be recommended as effective against the disease – as the pandemic continues to accelerate across the world. “These drugs offer hope for patients and families who are suffering from the devastating impact of severe and critical COVID-19,” …

Covaxin is 65.2% effective against Delta variant, says Bharat Biotech
3 years, 6 months ago

Covaxin is 65.2% effective against Delta variant, says Bharat Biotech

Op India  

On Saturday, Bharat Biotech announced the safety and efficacy analysis data from Phase-3 clinical trials of Covaxin – an indigenous vaccine developed to fight the deadly pandemic Covid-19. Citing pre-print data from the country’s largest efficacy trial, Bharat Biotech revealed that the Indian-made Covaxin achieved an overall efficacy of 77.8% against symptomatic Covid-19 patients. Here are the overall efficacy rates …

Expert panel approves Bharat Biotech's Covaxin for phase 2/3 trials on 2-18 year-olds
3 years, 7 months ago

Expert panel approves Bharat Biotech's Covaxin for phase 2/3 trials on 2-18 year-olds

India TV News  

Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organization on Tuesday deliberated upon Hyderabad-based Bharat Biotech's application seeking permission to conduct phase II/III clinical trials to evaluate …

Bharat Biotech's Covaxin Gets Approval for Phase 2/3 Trials on 2-18 Year-olds
3 years, 7 months ago

Bharat Biotech's Covaxin Gets Approval for Phase 2/3 Trials on 2-18 Year-olds

News 18  

Bharat Biotech’s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organization on Tuesday deliberated upon Hyderabad-based Bharat Biotech’s application seeking permission to conduct phase II/III clinical trials to evaluate …

Covaxin found to neutralise ‘617 variant’ of COVID-19, says Anthony Fauci
3 years, 8 months ago

Covaxin found to neutralise ‘617 variant’ of COVID-19, says Anthony Fauci

Firstpost  

The US administration is looking at options to share around 60 million doses with other countries over the next two months, a White House advisor said Washington: Covaxin, India’s home-grown COVID-19 vaccine, has been found to neutralise the 617 variant of the deadly virus, White House chief medical adviser and America’s top pandemic expert Dr Anthony Fauci said. Responding to …

Vaccination Works Incredibly Well, Data Show in Boost to India's Fight Against Covid-19
3 years, 8 months ago

Vaccination Works Incredibly Well, Data Show in Boost to India's Fight Against Covid-19

News 18  

Just four out of 10,000 people who were administered both doses of Bharat Biotech’s Covaxin and three out of 10,000 recipients of both doses of Oxford-AstraZeneca’s Covishield turned positive for Covid-19 after inoculation, government data showed on Wednesday, indicating that the vaccines available in India have hit the mark against the viral disease. In absolute numbers, 695 recipients among the …

In second COVID wave, Asia and Latin America suffer acute shortage of vaccines, health sectors overwhelmed
3 years, 8 months ago

In second COVID wave, Asia and Latin America suffer acute shortage of vaccines, health sectors overwhelmed

The Hindu  

The Asia-Pacific region has emergedas the epicentre of the latest COVID-19 pandemic surge. Meanwhile, the World Health Organisation’s COVAX scheme to help the nations of the global South is facing many hurdles, the major one being the acute shortage of vaccines. After India started its vaccination drive in March, Prime Minister Narendra Modi announced the government’s “vaccine friendship” initiative with …

Covaxin shows 78% efficacy in mild to severe Covid-19 cases: Bharat Biotech
3 years, 8 months ago

Covaxin shows 78% efficacy in mild to severe Covid-19 cases: Bharat Biotech

India Today  

Bharat Biotech on Wednesday announced results of its second interim analysis for Covaxin and said the vaccine has demonstrated an overall interim clinical efficacy of 78 per cent against mild, moderate and severe Covid-19. Apart from this, the result showed that Covaxin's efficacy against asymptomatic Covid-19 cases was 70 per cent, suggesting decreased transmission of the virus in recipients of …

Covaxin phase 2 data shows vaccine safe, induces immune response, says Lancet study
3 years, 10 months ago

Covaxin phase 2 data shows vaccine safe, induces immune response, says Lancet study

Firstpost  

New Delhi: India’s first indigenous vaccine against COVID-19, Covaxin, is safe and generates immune response without any serious side effects, according to the interim results of the phase 2 trials published in The Lancet Infectious Diseases journal. The phase 2 trial to evaluate the immunogenicity and safety of the BBV152 vaccine was conducted in healthy adults and adolescents aged 12-65 …

Coronavirus | Covaxin Phase-2 trials show vaccine safe, induces immune response, says Lancet study
3 years, 10 months ago

Coronavirus | Covaxin Phase-2 trials show vaccine safe, induces immune response, says Lancet study

The Hindu  

Covaxin, India’s indigenous COVID-19 vaccine, showed enhanced immune response as well as better reactogenicity and safety outcomes in the phase 2 trial, interim results that have now been published in the journal Lancet Infectious Diseases said. The publication comes days after Covaxin maker Bharat Biotech said the vaccine demonstrated an interim clinical efficacy of 81% in its later phase 3 …

Covaxin 81 per cent effective against Covid-19: Survey
3 years, 10 months ago

Covaxin 81 per cent effective against Covid-19: Survey

Deccan Chronicle  

Hyderabad: Covaxin developed by Bharat Biotech and the Indian Council for Medical Research has shown 81 per cent efficacy against Covid-19, based on a survey done on 25,800 participants, says an interim analysis of clinical trial results provided by the company. Dr Krishna Ella, chairman and managing director of Bharat Biotech, said, "Covaxin demonstrates high clinical efficacy against Covid-19 and …

Coronavirus | Covaxin efficacy is 81%, works against variants
3 years, 10 months ago

Coronavirus | Covaxin efficacy is 81%, works against variants

The Hindu  

Covaxin, India’s first COVID-19 vaccine, has demonstrated an interim clinical efficacy of 81% in the phase 3 clinical trial, vaccine maker Bharat Biotech said on Wednesday. Noting that the vaccine demonstrated the interim efficacy in preventing COVID-19 in those without prior infection after the second dose, the company said the 25,800 participants received a vaccine or placebo in a 1:1 …

Bharat Biotech releases Phase 3 results of Covaxin, says it shows 81% interim clinical efficacy
3 years, 10 months ago

Bharat Biotech releases Phase 3 results of Covaxin, says it shows 81% interim clinical efficacy

India Today  

Indian vaccine manufacturer Bharat Biotech on Wednesday announced results of Phase 3 clinical trials of its Covid-19 vaccine candidate, Covaxin, saying the vaccine demonstrates interim clinical efficacy of 81 per cent. Bharat Biotech said the Phase 3 clinical trials for Covaxin involved 25,800 volunteers, making it the "largest trials ever conducted in India" in collaboration with the Indian Council of …

Coronavirus | Clinical trials indicate India’s vaccines will be effective against COVID-19 variants: ICMR
3 years, 10 months ago

Coronavirus | Clinical trials indicate India’s vaccines will be effective against COVID-19 variants: ICMR

The Hindu  

Indian Council of Medical Research Director General Dr Balram Bhargava has said interim results of the ongoing clinical trials indicated that the indigenous Covid-19 vaccines would be effective against the mutated virus strains reported from the United Kingdom, South Africa and Brazil. In the case of the variants from South Africa and Brazil, efforts were on to isolate the mutated …

The Hindu Explains | How effective are the two COVID-19 vaccines rolled out in India, and are there concerns about safety?
3 years, 11 months ago

The Hindu Explains | How effective are the two COVID-19 vaccines rolled out in India, and are there concerns about safety?

The Hindu  

The story so far: Two COVID-19 vaccines, Covaxin and Covishield, after being granted emergency use authorisation, were rolled out on January 16 across India to inoculate 3 crore healthcare and frontline workers in the first phase of the vaccination drive. While Covaxin is produced under a collaboration between Bharat Biotech and the Indian Council of Medical Research, Covishield has been …

Covid-19 vaccine side-effects: What doctors who took the shot said
3 years, 11 months ago

Covid-19 vaccine side-effects: What doctors who took the shot said

India Today  

Billed as the world's largest vaccination programme, covering the entire length and breadth of the country, Prime Minister Narendra Modi launched the world's biggest Covid-19 inoculation drive on January 16 amid much euphoria across the country. Dr VK Paul - Chairman of the National Expert Group on Vaccine Administration for Covid-19 The World Health Organization is clamouring to provide vaccines …

Ready for COVID-19 vaccine roll-out within 10 days of approval, says health ministry; Boris Johnson postpones India trip
4 years ago

Ready for COVID-19 vaccine roll-out within 10 days of approval, says health ministry; Boris Johnson postpones India trip

Firstpost  

As India’s coronavirus cases rose to 1,03,56,844, the Union health ministry on Tuesday said it is prepared to introduce the COVID-19 vaccine by 13 January, within 10 days from date of Emergency Use Authorisation, but added that the final decision lies with the government. No ban on export of vaccine, clarifies health ministry Addressing a press briefing, Union health secretary …

Covaxin approval row: How India approves vaccines explained
4 years ago

Covaxin approval row: How India approves vaccines explained

India Today  

The restricted emergency approval given to a Covid-19 vaccine developed by Bharat Biotech on January 3 has created a huge furore with several experts questioning the government's decision. A key aspect of granting approval to a vaccine or a drug in India is the requirement of clinical trials conducted within the country - from phase-I to phase-III. Read: Covishield vs …

COVID-19 vaccine: DCGI grants approval to Covishield, Covaxin; Modi terms it 'decisive turning point'
4 years ago

COVID-19 vaccine: DCGI grants approval to Covishield, Covaxin; Modi terms it 'decisive turning point'

Firstpost  

The DCGI’s approval was given on the basis of recommendations submitted by a COVID-19 subject expert committee of the Central Drugs Standard Control Organisation India’s drugs regulator on Sunday approved Oxford’s COVID-19 vaccine Covishield, manufactured by the Serum Institute of India, and the indigenously-developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a …

Coronavirus | India approves COVID-19 vaccines Covishield and Covaxin for emergency use
4 years ago

Coronavirus | India approves COVID-19 vaccines Covishield and Covaxin for emergency use

The Hindu  

Vaccines by Bharat Biotech and Serum Institute of India were formally approved by the Central Drugs and Standards Committee on Sunday. However, a press statement by the Health Ministry said the vaccine’s efficacy in Indian volunteers was “comparable” to that tested in overseas trials. Bharat Biotech whose vaccine candidate was being tested in large phase-3 efficacy trial in India, has …

WHO welcomes India's coronavirus vaccine approval, says will help intensify fight against Covid
4 years ago

WHO welcomes India's coronavirus vaccine approval, says will help intensify fight against Covid

India Today  

The World Health Organisation on Sunday welcomed India's decision to give approval to Covid-19 vaccines for emergency use authorisation and said the move will "intensify and strengthen" the fight against the coronavirus pandemic. This decision taken today by India will help intensify and strengthen the fight against Covid-19 pandemic in the Region," Dr Poonam Khetrapal Singh, the regional director, WHO …

Bharat Biotech’s Covaxin Shows Long-term Immunity: Study
4 years ago

Bharat Biotech’s Covaxin Shows Long-term Immunity: Study

The Quint  

Covaxin is currently undergoing Phase 3 human clinical trials on 26,000 volunteers across 25 centres across India, after having undergone Phase 1 and 2 trials involving 1,000 volunteers. In a double-blind, randomised, multi-centre Phase 2 clinical trials, a total of 380 healthy children and adults were administered two vaccine formulations four weeks apart. In a follow-up of the Phase 1 …

Covid-19: What you need to know today
4 years ago

Covid-19: What you need to know today

Hindustan Times  

The US Food and Drug Administration’s endorsement of the Moderna vaccine’s safety and efficacy on Tuesday — a regulatory clearance is expected as early as Friday — came with a bonus: details, hitherto unknown, that indicated the vaccine’s ability to prevent or, at the least, reduce the transmission of Covid-19. Based on the trial data published in the public domain, …

Human trials of Russia’s Covid-19 vaccine candidate to begin in India this week
4 years, 1 month ago

Human trials of Russia’s Covid-19 vaccine candidate to begin in India this week

Hindustan Times  

Human trials for Sputnik-V, Russia’s vaccine candidate against the raging coronavirus disease pandemic is likely to start in India in the middle of this week, according to government officials. The Russian Direct Investment Fund had inked a deal with Dr. Reddy’s Laboratories, an Indian multinational pharmaceutical company headquartered in Hyderabad, for trials and distribution of its vaccine candidate in the …

Arthritis Drug May Improve Covid-19 Survival Among Elderly Patients, Says Study
4 years, 1 month ago

Arthritis Drug May Improve Covid-19 Survival Among Elderly Patients, Says Study

News 18  

A drug used to treat rheumatoid arthritis may reduce the risk of dying for elderly patients with COVID-19, and provide a new weapon in the arsenal against the novel coronavirus, according to a study. “We urgently need to find more effective treatments for COVID-19 while we wait for a vaccine to become widely available, said Professor Justin Stebbing, co-lead author …

How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast
4 years, 2 months ago

How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast

The Hindu  

As India continues to walk the challenging path of tackling COVID-19, this month there has been some excitement with regard to possible vaccines. At present, there are four vaccines in India in various stages of clinical trials — Bharat Biotech’s Covaxin, a vaccine by Zydus Cadila, AstraZeneca and the University of Oxford’s Covishield. Globally, there are over 150 vaccine candidates …

Bharat Biotech to conduct Phase 3 trials for COVAXIN on 26,000 people in 25 centres
4 years, 2 months ago

Bharat Biotech to conduct Phase 3 trials for COVAXIN on 26,000 people in 25 centres

India Today  

The Bharat Biotech will be conducting Phase 3 trials for its Covid-19 vaccine candidate, COVAXIN, in 25 centres across India and a total of 26,000 people will be participating in the Phase 3 trials. The Drug Controller General of India has already granted Bharat Biotech a go ahead for the Phase 3 trials after successful completion of Phase 1 and …

Timely treatment with tocilizumab likely to improve clinical outcomes in severe COVID-19 patients, finds study
4 years, 2 months ago

Timely treatment with tocilizumab likely to improve clinical outcomes in severe COVID-19 patients, finds study

Firstpost  

The drug is already approved and is used for the treatment of rheumatoid arthritis, an autoimmune disease that leads to joint inflammation and pain Patients with severe COVID-19 are likely to have short-term mortality rates between 35 percent to 62 percent, according to a study published in the journal JAMA Internal Medicine. A group of researchers at US’ Birmingham and …

India far from achieving herd immunity: Harsh Vardhan
4 years, 3 months ago

India far from achieving herd immunity: Harsh Vardhan

Live Mint  

India is far from achieving herd immunity for covid-19, Union minister Harsh Vardhan said on Sunday while interacting with people on social media during the third episode of Sunday Samvaad. “The soon to be released second sero survey indications are that we are far from having achieved any kind of herd immunity which necessitates that all of us should continue …

How Can A Writ Court Decide If Allopathy Or Ayurveda Will Work For COVID-19 Treatment? Karnataka HC Asks
4 years, 4 months ago

How Can A Writ Court Decide If Allopathy Or Ayurveda Will Work For COVID-19 Treatment? Karnataka HC Asks

Live Law  

"How can a writ court decide whether allopathy treatment will work or whether ayurvedic treatment will work while treating a patient infected with COVID-19," the Karnataka High Court observed on Thursday while hearing a public interest litigation filed by two qualified practitioners of Ayurveda. Clinical Management Protocol: Covid-19" issued by the Ministry of Health and Family Welfare, Government of India …

Russia Shares 'Comprehensive Data' on Covid-19 Shot 'Sputnik V' with India, Phase 3 Trials an Option
4 years, 4 months ago

Russia Shares 'Comprehensive Data' on Covid-19 Shot 'Sputnik V' with India, Phase 3 Trials an Option

News 18  

Close on the heels of The Lancet publishing the outcome of the Phase-1 and Phase-2 clinical trial data of Russia’s potential Covid-19 shot Sputnik V, the Russian research institute has presented “comprehensive data” on the vaccine’s safety to Indian authorities, The Indian Express reported. As per the details available on the official website of Sputnik V, Russia aims to conduct …

Ayurveda for treating Covid-19 patients? India, US to initiate joint clinical trials
4 years, 6 months ago

Ayurveda for treating Covid-19 patients? India, US to initiate joint clinical trials

Live Mint  

Washington: Ayurvedic practitioners and researchers in India and the US are planning to initiate joint clinical trials for Ayurveda formulations against the novel coronavirus, the Indian envoy here has said. In a virtual interaction with a group of eminent Indian-American scientists, academicians, and doctors on Wednesday, Indian Ambassador to the US Taranjit Singh Sandhu said the vast network of institutional …

COVID-19 treatments: Which drugs, therapies are proven to work, and which ones don’t?
4 years, 6 months ago

COVID-19 treatments: Which drugs, therapies are proven to work, and which ones don’t?

Firstpost  

We have made amazing progress in the treatment of COVID-19. Ritonavir increases the level of Lopinavir in the blood so the lopinavir/ritonavir combination was tested in a randomized controlled clinical trial for COVID-19. Steroids – yes for almost all COVID-19 patients When a synthetic steroid hormone, called dexamethasone, was given to patients with COVID-19 the drug decreased 28-day mortality by …

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients
4 years, 6 months ago

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients

Firstpost  

Over nine million people globally have tested positive for COVID-19 so far, of which, 4,25,000 are in India. Glenmark Pharmaceuticals, a research-led pharmaceutical company, received the approval for manufacturing and marketing Favipiravir, an antiviral drug to be used for the treatment of mild to moderate COVID-19 patients, from the Drugs Controller General of India on Friday, 19 June 2020. Favipiravir: …

Glenmark to conduct phase-3 ‘FAITH’ trial in hospitalised patients with moderate COVID-19 infection
4 years, 7 months ago

Glenmark to conduct phase-3 ‘FAITH’ trial in hospitalised patients with moderate COVID-19 infection

The Hindu  

As the number of COVID-19 patients are rising in India, Glenmark Pharmaceuticals Ltd has announced a new randomized, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment strategy. The two antiviral drugs have different mechanisms of action, and their combination may demonstrate improved treatment efficacy by effectively tackling high viral …

Glenmark to study potential COVID-19 drug combination; to look to enroll 158 hospitalised patients
4 years, 7 months ago

Glenmark to study potential COVID-19 drug combination; to look to enroll 158 hospitalised patients

Firstpost  

On 1 May, Glenmark Pharmaceuticals said it has become the first company in India to receive approval from Drug Controller General of India to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients. Glenmark Pharmaceuticals Ltd said on Tuesday it will begin a new clinical trial in India to test a combination of two anti-viral drugs …

Discover Related